8.4-PNEUMOCYSTIS PNEUMONIA+PENICILLIOSIS+OTHER OPPORTUNISTIC MYCOSES Flashcards

1
Q

What organism causes Pneumocystis pneumonia (PCP)?

A

Pneumocystis jiroveci (formerly P. carinii)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What type of patients does P. jiroveci primarily affect?

A

Immunocompromised patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How common is dissemination of P. jiroveci?

A

Rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Before the AIDS epidemic, what was the main population affected by P. jiroveci?

A

Malnourished infants and immunosuppressed patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Before effective prophylaxis, what was a major cause of death in AIDS patients?

A

Pneumocystis pneumonia (PCP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What organs can P. jiroveci affect apart from the lungs?

A

Spleen, lymph nodes, bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the major stages in the life cycle of P. jiroveci?

A

Trophozoite → Precyst → Cyst → Sporozoites → Trophozoites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the function of trophozoites in P. jiroveci?

A

Feeding stage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is P. jiroveci an intracellular or extracellular pathogen?

A

Extracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where does P. jiroveci grow in the lung?

A

Surfactant layer above alveolar epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the two morphologically distinct forms of P. jiroveci?

A

Thin-walled trophozoites and thick-walled cysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the characteristics of the cysts?

A

Thick-walled, spherical to elliptical (4–6 µm), containing 4–8 nuclei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What surface marker is found in P. jiroveci and can be detected in sera?

A

Surface glycoprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the ideal specimen for diagnosing Pneumocystis pneumonia?

A

Bronchoalveolar lavage (BAL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What other specimens can be used?

A

Lung biopsy tissue, induced sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What stains are appropriate for detecting P. jiroveci?

A

Giemsa, toluidine blue, methenamine silver, calcofluor white

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Can P. jiroveci be cultured?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Does P. jiroveci cause disease in immunocompetent individuals?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Has a natural reservoir for P. jiroveci been identified?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is known about the mode of infection for P. jiroveci?

A

Unclear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When are most individuals infected with P. jiroveci?

A

Early childhood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the global distribution of P. jiroveci?

A

Worldwide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What type of immunity plays a dominant role in resistance to disease?

A

Cell-mediated immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

At what CD4 count does Pneumocystis pneumonia usually appear in AIDS patients?

A

Below 400 cells/µL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the two main treatment options for Pneumocystis pneumonia?

A

Trimethoprim-sulfamethoxazole or pentamidine isethionate

26
Q

How can prophylaxis be achieved?

A

Daily trimethoprim-sulfamethoxazole or aerosolized pentamidine

27
Q

What organism causes Penicilliosis?

A

Penicillium marneffei (Talaromyces marneffei)

28
Q

What type of infection does P. marneffei cause?

A

Systemic infection in immunocompromised patients

29
Q

How has P. marneffei emerged as a pathogen?

A

As an endemic, opportunistic pathogen

30
Q

In which regions is P. marneffei endemic?

A

Southeast Asia, including China, Thailand, Vietnam, Indonesia, Hong Kong, Taiwan, Manipur (India)

31
Q

Where is P. marneffei commonly isolated from?

A

Soil, especially soil associated with bamboo rats and their habitats

32
Q

What is the colonial appearance of P. marneffei in mold form?

A

Green-yellow colony with diffusible reddish pigment

33
Q

What is the microscopic appearance of P. marneffei in mold form?

A

Septate, branching hyphae, brushlike aerial conidiospores, phialides, and basipetal chains of conidia

34
Q

What is the microscopic appearance of P. marneffei in tissue form?

A

Unicellular yeast-like cells (2 × 6 µm) dividing by fission

35
Q

What are the major risk factors for Penicilliosis?

A

HIV/AIDS, tuberculosis, corticosteroid treatment, lymphoproliferative diseases

36
Q

What are the clinical manifestations of Penicilliosis?

A

Fungemia, skin lesions, systemic involvement (especially reticuloendothelial system)

37
Q

What are the signs and symptoms of Penicilliosis?

A

Cough, fever, fatigue, weight loss, lymphadenopathy, cutaneous/subcutaneous papules or rashes

38
Q

What specimens are used for diagnosing Penicilliosis?

A

Skin, blood, or tissue biopsies

39
Q

How is Penicilliosis diagnosed?

A

Microscopic observation of yeast-like cells and positive cultures

40
Q

What is the treatment for Penicilliosis?

A

Amphotericin B (initial course), Itraconazole (follow-up therapy)

41
Q

What are opportunistic mycoses?

A

Globally distributed fungal infections with high incidence, severity, and mortality

42
Q

What innate host defenses protect against systemic candidiasis, invasive aspergillosis, and mucormycosis?

A

Neutrophils & monocytes

43
Q

What types of patients are at high risk for opportunistic mycoses?

A

Those with hematologic dyscrasias, immunosuppressive or cytotoxic drug treatment

44
Q

What fungal infections commonly affect HIV/AIDS patients?

A

Mucosal candidiasis (e.g., thrush, esophagitis)

45
Q

Which fungal infections occur in AIDS patients with CD4 counts <100 cells/µL?

A

Cryptococcosis, Pneumocystis pneumonia, Aspergillosis, Penicilliosis, Endemic mycoses

46
Q

Why is invasive aspergillosis or candidiasis difficult to diagnose?

A

Blood cultures are negative in aspergillosis, <50% positive in systemic candidiasis

47
Q

What is the key to successful management of opportunistic mycoses?

A

Early diagnosis, rapid antifungal therapy, control of underlying disease

48
Q

What diseases does Geotrichum candidum cause?

A

Pulmonary disease, wound infections, and oral thrush

49
Q

What is the key microscopic feature of Geotrichum candidum?

A

Abundant arthroconidia due to fragmentation of hyphae

50
Q

What disease is Fusarium commonly associated with?

A

Mycotic keratitis

51
Q

What is the distinctive microscopic feature of Fusarium?

A

Banana- or canoe-shaped macroconidia clustered in mats (sporodochia)

52
Q

What is unique about Fusarium macroconidia?

A

Only mycoses with banana-/canoe-shaped macroconidia

53
Q

What are the colony colors of Fusarium?

A

Rose, mauve, purple, yellow

54
Q

What are opportunistic mycoses?

A

Globally distributed fungal infections that cause high morbidity and mortality in immunocompromised patients

55
Q

Which mycoses have the highest incidence, severity, and mortality?

A

Systemic opportunistic mycoses

56
Q

What innate host defenses protect against systemic opportunistic mycoses?

A

Neutrophils & monocytes

57
Q

What part of the immune system plays an additional role in defense?

A

Adaptive immune response, particularly cell-mediated immunity

58
Q

What patients are at high risk for opportunistic mycoses?

A

Patients with hematologic dyscrasias (e.g., leukemia, anemia) and immunosuppressive or cytotoxic drug treatment

59
Q

What fungal infection is common in most HIV/AIDS patients?

A

Mucosal candidiasis (thrush, esophagitis)

60
Q

Patients with CD4 counts <100 cells/µL are at risk for what infections?

A

Cryptococcosis, Pneumocystis pneumonia, Aspergillosis, Penicilliosis, Endemic mycoses, Other opportunistic fungal infections